Literature DB >> 10882150

Female pseudohermaphroditism and inefficient peak bone mass in an untreated subject affected by 21-hydroxylase congenital adrenal hyperplasia.

R Valentino1, S Savastano, A P Tommaselli, M Dorato, M T Scarpitta, E Calvanese, A Del Puente, G Lombardi.   

Abstract

Here we describe a subject with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-CAH), in its classical virilizing form, who presented at birth ambiguous genitalia and subsequently was assigned by the parents as male. At the age of 8 years, he underwent a two-step surgical correction of hypospadia and at 22 years old, uterus and ovaries were removed and a bilateral testicular prothesis was surgically placed in scrotum. He refused any chronic glucocorticoid therapy, that was given only acutely to prevent adrenal crises during stress, trauma surgery or severe illness. The patient is now 38 years old, he is genotypically female but phenotypically male, with high endogenous levels of androgen, all of adrenal origin, and with an apparent male sexual life. He had severe osteopenia, probably due to the lack of estrogen/androgen-induced increase in bone mineral density, although periferal estrogen conversion was normal. His skeletal mass, in fact, normally acquired during adolescence and early adult life, could in this case be inefficient, for the precocious pseudopuberty, that caused an inefficient peak bone mass in adolescence period.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882150     DOI: 10.1007/BF03343729

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males.

Authors:  B Ongphiphadhanakul; R Rajatanavin; S Chanprasertyothin; N Piaseu; L Chailurkit
Journal:  Clin Endocrinol (Oxf)       Date:  1998-12       Impact factor: 3.478

Review 2.  Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.

Authors:  E Canalis
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

Review 3.  The influence of estrogen on growth.

Authors:  P A Lee; S F Witchel
Journal:  Curr Opin Pediatr       Date:  1997-08       Impact factor: 2.856

Review 4.  Disorders of adrenal steroid biogenesis.

Authors:  A M Bongiovanni; W R Eberlein; A S Goldman; M New
Journal:  Recent Prog Horm Res       Date:  1967

5.  The association between congenital adrenal hyperplasia and HLA in Southern Italy.

Authors:  S Zappacosta; M Maio; M de Felice; R Valentino
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

Review 6.  Osteoporosis in men.

Authors:  E S Orwoll; R F Klein
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

7.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.

Authors:  E P Smith; J Boyd; G R Frank; H Takahashi; R M Cohen; B Specker; T C Williams; D B Lubahn; K S Korach
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

Review 8.  The role of estrogen in bone growth and maturation during childhood and adolescence.

Authors:  G B Cutler
Journal:  J Steroid Biochem Mol Biol       Date:  1997-04       Impact factor: 4.292

9.  Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.

Authors:  G Theintz; B Buchs; R Rizzoli; D Slosman; H Clavien; P C Sizonenko; J P Bonjour
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

Review 10.  Genetic disorders of adrenal hormone synthesis.

Authors:  M I New
Journal:  Horm Res       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.